Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16).
- Authors
- Kim, SH[Kim, Se Hyun]; Suh, KJ[Suh, Koung Jin]; Im, SA[Im, Seock-Ah]; Lee, KH[Lee, Kyung-Hun]; Kim, MH[Kim, Min Hwan]; Sohn, J[Sohn, Joohyuk]; Park, YH[Park, Yeon Hee]; Kim, JY[Kim, Ji-Yeon]; Jeong, JH[Jeong, Jae Ho]; Lee, KE[Lee, Kyoung Eun]; Choi, IS[Choi, In Sil]; Park, KH[Park, Kyong Hwa]; Kim, HJ[Kim, Hee Jun]; Cho, EK[Cho, Eun Kyung]; Park, SY[Park, So Yeon]; Kim, M[Kim, Milim]; Kim, JH[Kim, Jee Hyun]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.